Sort
89,613 grants matching “depression”
Mechanisms Of Synaptic Plasticity In The Adult And Developing Nervous System
$3,430,056Serena M Dudek · National Institute Of Environmental Health Sciences · ZIA · FY2015 · ES
Cellular And Synaptic Physiology Of Hippocampal Interneurons
$3,426,623Chris J McBain · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2009 · HD
Multicenter AIDS Cohort Study - Part B (Baltimore Center)
$3,422,677Joseph B. Margolick · Johns Hopkins University · U01 · FY2015 · AI
Implementing Behavioral Health in Primary Care by Leveraging AHRQ Networks
$3,421,521Keith Kanel · Pittsburgh Regional Health Initiative · R18 · FY2010 · HS
Development of a monoclonal antibody to reverse overdose from fentanyl and its analogs: from manufacturing to clinical trials
$3,410,308Marco Pravetoni · University Of Washington · UH3 · FY2025 · DA
Gut Liver Brain Biochemical Axis in Alzheimer's Disease
$3,407,970Rima F Kaddurah-Daouk · Duke University · RF1 · FY2018 · AG
Preclinical and clinical evaluation of the NMDA modulator NYX-783 for OUD
$3,406,895Rajita Sinha · Yale University · UH3 · FY2022 · DA
Integrating Tailored Postoperative Opioid Tapering and Pain Management Support for Patients on Long-Term Opioid Use Presenting for Spine Surgery (MIRHIQL)
$3,406,550Jennifer Hah · Stanford University · R01 · FY2023 · DA
Implementing and Personalizing Best-In-Class Opioid-sparing Pain Management for Major Inpatient Surgeries in Children
$3,404,830Senthilkumar Sadhasivam · University Of Pittsburgh At Pittsburgh · U01 · FY2024 · HD
Efficacy of intravenous sub-dissociative ketamine versus intravenous morphine in children with acute pain.
$3,403,269Daniel Sing-Kwong Tsze · Columbia University Health Sciences · U01 · FY2024 · HD
Psychedelics for Older Adults with Chronic Pain
$3,399,999Stacy M Fischer · University Of Colorado Denver · UG3 · FY2025 · AG
East Africa International Epidemiology Database to evaluate AIDS (IeDEA) Regional Consortium
$3,398,030Kara Kay Wools-Kaloustian · Indiana University Indianapolis · U01 · FY2023 · AI
Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN)
$3,394,365Lorenzo Leggio · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2019 · AA
Integrative genetics of behavior with high throughput technologies
$3,384,629David Goldman · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2011 · AA
Food-Body-Mind Intervention: Promote whole child health
$3,382,581Jiying Ling · Michigan State University · UH3 · FY2025 · AT
Addressing emotional distress in dyads of persons with a Young Onset Dementia (YOD) and their care-partners
$3,379,666Ana-Maria Vranceanu · Massachusetts General Hospital · RF1 · FY2025 · AG
Advancing womenâs care in Alzheimerâs disease and other dementias through EHR
$3,377,863Sunghwan Sohn · Mayo Clinic Rochester · RF1 · FY2025 · AG
Non-invasive Neuromodulation Unit (NNU)
$3,375,712Sarah Lisanby · National Institute Of Mental Health · ZIA · FY2019 · MH
HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU)
$3,372,423Stephen A Spector · University Of California, San Diego · UM1 · FY2019 · AI
Integration of Genomics & Transcriptomics in Normal Twins & Major Depression
$3,370,853Patrick F Sullivan · Univ Of North Carolina Chapel Hill · RC2 · FY2009 · MH
NIMH Center for Collaborative Genetic Studies
$3,370,690Jay Arnold Tischfield · Rutgers, The State Univ Of N.J. · U24 · FY2009 · MH
Increasing financial and health equity among low income black youth and young adults
$3,369,104Sheri Ann Lippman · University Of California, San Francisco · U01 · FY2021 · OD
The VITamin D and OmegA-3 TriaL (VITAL)
$3,368,726Joann Elisabeth Manson · Brigham And Women'S Hospital · R01 · FY2019 · CA
PET Radiopharmaceutical Sciences
$3,368,404Victor W Pike · National Institute Of Mental Health · ZIA · FY2015 · MH
Neurobiology and Target Validation of Novel Therapeutic Agents in Mood Disorders
$3,366,147Carlos Zarate · National Institute Of Mental Health · ZIA · FY2024 · MH